Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.
Sanofi sees US FDA ruling for MS drug Lemtrada in Q4
Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?
Effects of functional electrical stimulation on gait function and quality of life for people with multiple sclerosis taking dalfampridine.
Recurrence of disease activity after repeated Natalizumab withdrawals.
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Teva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of Relapsing-Remitting Multiple Sclerosis
The effect of Nintendo(R) Wii(R) on balance in people with multiple sclerosis: a pilot randomized control study.
Physical Activity Behavior Change in Persons With Neurologic Disorders: Overview and Examples From Parkinson Disease and Multiple Sclerosis.
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.
Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Long-term follow-up of vanishing tumors in the brain: How should a lesion mimicking primary CNS lymphoma be managed?
The effects of massage therapy on multiple sclerosis patients' quality of life and leg function.
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.
Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.
Magnetic resonance imaging in multiple sclerosis - patients' experiences, information interests and responses to an education programme.
Normal outcome of pregnancy with ongoing treatment with natalizumab.
High dose naltrexone for dyskinesias induced by levodopa.
Comprehending the inexplicable: qualitative accounts of black Caribbean and white british people severely affected by multiple sclerosis.
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Complementary and alternative medicine in multiple sclerosis.

Pages